PMID- 23771673 OWN - NLM STAT- MEDLINE DCOM- 20140911 LR - 20211021 IS - 1672-0733 (Print) IS - 1672-0733 (Linking) VI - 33 IP - 3 DP - 2013 Jun TI - Changes in HIF-1alpha, VEGF, NGF and BDNF levels in cerebrospinal fluid and their relationship with cognitive impairment in patients with cerebral infarction. PG - 433-437 LID - 10.1007/s11596-013-1137-4 [doi] AB - This study was carried out to investigate the role of intrinsic neuroprotective mechanisms in the occurrence and development of vascular cognitive impairment (VCI) with the goal of providing a target for the treatment and prevention of VCI. Inpatients with proven cerebral infarction on cranial computed tomography (CT) were recruited as the ischemic cerebrovascular diseases (ICVD) group, and the patients with mixed stroke were excluded. In ICVD group, 12 patients were diagnosed as having VCI and served as VCI group. Inpatients undergoing surgical operation in our hospital were enrolled as control group. Double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) was employed to detect the levels of hypoxia-inducible factor 1-alpha (HIF-1alpha), vascular endothelial growth factor (VEGF), nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in the cerebrospinal fluid of patients with ICVD. Associations between the levels of these factors and the Mini-Mental State Examination (MMSE) score were evaluated. In ICVD and VCI groups, the levels of HIF-1alpha and NGF in the cerebrospinal fluid were markedly lower than those in control group (P=0.037 and P=0.000; P=0.023 and P=0.005). In ICVD and VCI groups, the MMSE score was negatively related to VEGF level in the cerebrospinal fluid (r=-0.327, P=0.021; r=-0.585, P=0.046). In VCI group, HIF-1alpha level was correlated with NGF level (r=0.589, P=0.044). HIF-1alpha and NGF are involved in ischemic and hypoxic cerebral injury. The HIF signaling pathway plays an important role in intrinsic neuroprotection. Upregulation and maintenance of HIF-1alpha and NGF expression may attenuate VCI. Changes in VEGF levels are related to the occurrence and development of cognitive impairment. FAU - Ke, Xian-Jun AU - Ke XJ AD - Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. FAU - Zhang, Jun-Jian AU - Zhang JJ AD - Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. wdsjkx@163.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130617 PL - China TA - J Huazhong Univ Sci Technolog Med Sci JT - Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban JID - 101169627 RN - 0 (Biomarkers) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (HIF1A protein, human) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (VEGFA protein, human) RN - 0 (Vascular Endothelial Growth Factor A) RN - 7171WSG8A2 (BDNF protein, human) RN - 9061-61-4 (Nerve Growth Factor) SB - IM MH - Biomarkers/cerebrospinal fluid MH - Brain-Derived Neurotrophic Factor/*cerebrospinal fluid MH - Cerebral Infarction/*cerebrospinal fluid/complications/diagnosis MH - Cognition Disorders/*cerebrospinal fluid/complications/diagnosis MH - Female MH - Humans MH - Hypoxia-Inducible Factor 1, alpha Subunit/*cerebrospinal fluid MH - Male MH - Middle Aged MH - Nerve Growth Factor/*cerebrospinal fluid MH - Reproducibility of Results MH - Sensitivity and Specificity MH - Vascular Endothelial Growth Factor A/*cerebrospinal fluid EDAT- 2013/06/19 06:00 MHDA- 2014/09/12 06:00 CRDT- 2013/06/18 06:00 PHST- 2012/12/26 00:00 [received] PHST- 2013/06/18 06:00 [entrez] PHST- 2013/06/19 06:00 [pubmed] PHST- 2014/09/12 06:00 [medline] AID - 10.1007/s11596-013-1137-4 [pii] AID - 10.1007/s11596-013-1137-4 [doi] PST - ppublish SO - J Huazhong Univ Sci Technolog Med Sci. 2013 Jun;33(3):433-437. doi: 10.1007/s11596-013-1137-4. Epub 2013 Jun 17.